Germany
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
15.87 |
Jan. 14, 2025 | USD 3.95 | -0.95% |
|
Germany |
|
2 |
13.12 |
Jan. 14, 2025 | USD 5.29 | 13.28% |
|
Germany |
|
3 |
12.46 |
Jan. 14, 2025 | USD 60.50 | -1.24% |
|
Germany |
|
4 |
11.32 |
Jan. 14, 2025 | USD 2.61 | 0.60% |
|
Germany |
|
5 |
6.73 |
Jan. 14, 2025 | USD 116.36 | -0.45% |
|
Germany |
|
6 |
6.51 |
Jan. 14, 2025 | USD 4.96 | -2.24% |
|
Germany |
|
7 |
5.24 |
Jan. 14, 2025 | USD 1.49 | -0.76% |
|
Germany |
|
8 |
3.76 |
Jan. 14, 2025 | USD 48.95 | 1.72% |
|
Germany |
|
9 |
2.72 |
Jan. 14, 2025 | USD 145.16 | 0.75% |
|
Germany |
|
10 |
2.47 |
Jan. 14, 2025 | USD 1.09 | 3.54% |
|
Germany |
|
11 |
1.87 |
Jan. 14, 2025 | USD 42.87 | 0.60% |
|
Germany |
|
12 |
1.67 |
Jan. 14, 2025 | USD 8.09 | -2.02% |
|
Germany |
|
13 |
1.40 |
Jan. 14, 2025 | USD 3.68 | 1.46% |
|
Germany |
|
14 |
1.40 |
Jan. 14, 2025 | USD 49.86 | 0.81% |
|
Germany |
|
15 |
1.22 |
Jan. 14, 2025 | USD 29.11 | 3.16% |
|
Germany |
|
16 |
1.09 |
Jan. 14, 2025 | USD 21.54 | 1.09% |
|
Germany |
|
17 |
0.86 |
Jan. 14, 2025 | USD 4.18 | 0.60% |
|
Germany |
|
18 |
0.79 |
Feb. 28, 2024 | USD 12.40 | 1.02% |
NA
|
Germany |
|
19 |
0.44 |
Jan. 14, 2025 | USD 18.55 | -3.93% |
|
Germany |
|
20 |
0.38 |
Jan. 14, 2025 | USD 20.20 | -1.60% |
|
Germany |
The Biotechnology company in Germany with the highest Price to Sales Ratio (P/S) is CureVac N.V. (Frankfurt Stock Exchange: 5CV.F) at 15.87.
The Biotechnology company in Germany with the lowest Price to Sales Ratio (P/S) is Bayer Aktiengesellschaft (XETRA: BAYN.DE) at 0.38.
The top 10 Biotechnology companies in Germany by Price to Sales Ratio (P/S) are CureVac N.V., Mainz Biomed B.V., Formycon AG, Heidelberg Pharma AG, BioNTech SE, SynBiotic SE, NanoRepro AG, Eckert & Ziegler Strahlen- und Medizintechnik AG, MERCK Kommanditgesellschaft auf Aktien and Medigene AG.
The bottom 10 Biotechnology companies in Germany by Price to Sales Ratio (P/S) are Bayer Aktiengesellschaft, technotrans SE, CropEnergies AG, VITA 34 AG, Nynomic AG, Stratec SE, GEA Group Aktiengesellschaft, BRAIN Biotech AG, Evotec SE and Biotest Aktiengesellschaft.